PTC Therapeutics, Inc. PTCT

Updated: 10 Sep 2026

NASDAQ | Biotech | Biopharmaceuticals and rare diseases

No signal published yet

We already track PTC Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow PTC Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceuticals and rare diseases
We're already tracking PTC Therapeutics, Inc. — here are the latest events we've registered

Recent News

  • On August 12, 2026, PTC Therapeutics announced an agreement to acquire ST-920, a BLA-stage gene therapy program for Fabry disease. Additionally, on August 24, 2026, the company presented new clinical data for Sephience demonstrating sustained metabolic control in phenylketonuria patients.

What Firelda Watch includes for PTC Therapeutics, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of PTC Therapeutics, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Black Mammoth Metals Corp
BMM
NEUTRAL
Crustal Resources B
HOLD
Crustal Minerals
CRUST B
NEUTRAL
Bioarctic
BIOA B
BUY
Swedish Orphan Biovitrum AB (publ)
SOBI
HOLD

Biotech

More companies in this sector

Want to follow PTC Therapeutics, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow PTC Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

PTC Therapeutics, Inc. PTCT
PTC Therapeutics — follow and we'll monitor it
Follow PTC Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.